ALR Technologies Inc. is a data management company. The Company is engaged in the development of a comprehensive approach to diabetes care that includes a Food and Drug Administration (FDA) cleared diabetes management system (the Diabetes Solution), which collects data directly from blood glucose meters (BGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. The Company has developed the Diabetes Solution for human health, and the GluCurve, a modified version of the Diabetes Solution, for animal health (GluCurve) from its technology portfolio. The Company has developed its Diabetes Solution, which is a comprehensive approach to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies. Its subsidiaries include ALR Technologies SG Pte. Ltd. and Canada Diabetes Solution Centre Inc.
ALR TECHNOLOGIES SG LTD. 
